201
|
CAI ZY, YAN Y, YAN L, Wang FY, Huang H, Wang YL, Zhao Y. Serum level of MMP-2, MMP-9 and Ox-LDL in Alzheimer's disease with hyperlipoidemia. ACTA ACUST UNITED AC 2007. [DOI: 10.1016/s1000-1948(08)60017-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
202
|
Twenty years of metallo-neurobiology: where to now? EUROPEAN BIOPHYSICS JOURNAL: EBJ 2007; 37:241-5. [PMID: 17994233 DOI: 10.1007/s00249-007-0228-1] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/03/2007] [Revised: 10/02/2007] [Accepted: 10/09/2007] [Indexed: 12/19/2022]
Abstract
The redox active transition metals Cu2+ and Fe3+ have been proposed as important factors in the neuropathology of Alzheimer's disease (AD) and other neurodegenerative diseases. The field that has been called metallo-neurobiology has expanded greatly in the last 20 years. Although there is much experimental evidence on various aspects of the interaction between these metals and the molecular and supramolecular components of the neuropil and the structural biology of metal binding, we are far from fully understanding the part this interaction plays in the normal CNS and in neurodegeneration. This understanding is needed if we are to move beyond the promising, but semi-empirical, approaches to therapies of these diseases based on metal attenuation.
Collapse
|
203
|
Caragounis A, Du T, Filiz G, Laughton K, Volitakis I, Sharples R, Cherny R, Masters C, Drew S, Hill A, Li QX, Crouch P, Barnham K, White A. Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands. Biochem J 2007; 407:435-50. [PMID: 17680773 PMCID: PMC2275059 DOI: 10.1042/bj20070579] [Citation(s) in RCA: 52] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Biometals have an important role in AD (Alzheimer's disease) and metal ligands have been investigated as potential therapeutic agents for treatment of AD. In recent studies the 8HQ (8-hydroxyquinoline) derivative CQ (clioquinol) has shown promising results in animal models and small clinical trials; however, the actual mode of action in vivo is still being investigated. We previously reported that CQ-metal complexes up-regulated MMP (matrix metalloprotease) activity in vitro by activating PI3K (phosphoinositide 3-kinase) and JNK (c-jun N-terminal kinase), and that the increased MMP activity resulted in enhanced degradation of secreted Abeta (amyloid beta) peptide. In the present study, we have further investigated the biochemical mechanisms by which metal ligands affect Abeta metabolism. To achieve this, we measured the effects of diverse metal ligands on cellular metal uptake and secreted Abeta levels in cell culture. We report that different classes of metal ligands including 8HQ and phenanthroline derivatives and the sulfur compound PDTC (pyrrolidine dithiocarbamate) elevated cellular metal levels (copper and zinc), and resulted in substantial loss of secreted Abeta. Generally, the ability to inhibit Abeta levels correlated with a higher lipid solubility of the ligands and their capacity to increase metal uptake. However, we also identified several ligands that potently inhibited Abeta levels while only inducing minimal change to cellular metal levels. Metal ligands that inhibited Abeta levels [e.g. CQ, 8HQ, NC (neocuproine), 1,10-phenanthroline and PDTC] induced metal-dependent activation of PI3K and JNK, resulting in JNK-mediated up-regulation of metalloprotease activity and subsequent loss of secreted Abeta. The findings in the present study show that diverse metal ligands with high lipid solubility can elevate cellular metal levels resulting in metalloprotease-dependent inhibition of Abeta. Given that a structurally diverse array of ligands was assessed, the results are consistent with the effects being due to metal transport rather than the chelating ligand interacting directly with a receptor.
Collapse
Affiliation(s)
- Aphrodite Caragounis
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- †The Mental Health Research Institute, Parkville, Victoria 3052, Australia
- ‡Centre for Neuroscience, The University of Melbourne, Victoria 3010, Australia
| | - Tai Du
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- †The Mental Health Research Institute, Parkville, Victoria 3052, Australia
- ‡Centre for Neuroscience, The University of Melbourne, Victoria 3010, Australia
| | - Gulay Filiz
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- †The Mental Health Research Institute, Parkville, Victoria 3052, Australia
- ‡Centre for Neuroscience, The University of Melbourne, Victoria 3010, Australia
| | - Katrina M. Laughton
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- †The Mental Health Research Institute, Parkville, Victoria 3052, Australia
| | - Irene Volitakis
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- ‡Centre for Neuroscience, The University of Melbourne, Victoria 3010, Australia
| | - Robyn A. Sharples
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- †The Mental Health Research Institute, Parkville, Victoria 3052, Australia
- §Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3052, Australia
- ∥Department of Biochemistry and Molecular Biology, The University of Melbourne, Victoria 3010, Australia
| | - Robert A. Cherny
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- †The Mental Health Research Institute, Parkville, Victoria 3052, Australia
| | - Colin L. Masters
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- †The Mental Health Research Institute, Parkville, Victoria 3052, Australia
- ‡Centre for Neuroscience, The University of Melbourne, Victoria 3010, Australia
| | - Simon C. Drew
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- †The Mental Health Research Institute, Parkville, Victoria 3052, Australia
- §Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3052, Australia
| | - Andrew F. Hill
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- †The Mental Health Research Institute, Parkville, Victoria 3052, Australia
- §Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3052, Australia
- ∥Department of Biochemistry and Molecular Biology, The University of Melbourne, Victoria 3010, Australia
| | - Qiao-Xin Li
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- †The Mental Health Research Institute, Parkville, Victoria 3052, Australia
| | - Peter J. Crouch
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- †The Mental Health Research Institute, Parkville, Victoria 3052, Australia
- ‡Centre for Neuroscience, The University of Melbourne, Victoria 3010, Australia
| | - Kevin J. Barnham
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- †The Mental Health Research Institute, Parkville, Victoria 3052, Australia
- §Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3052, Australia
| | - Anthony R. White
- *Department of Pathology, The University of Melbourne, Victoria 3010, Australia
- †The Mental Health Research Institute, Parkville, Victoria 3052, Australia
- ‡Centre for Neuroscience, The University of Melbourne, Victoria 3010, Australia
- To whom correspondence should be addressed (email )
| |
Collapse
|
204
|
Du T, Filiz G, Caragounis A, Crouch PJ, White AR. Clioquinol promotes cancer cell toxicity through tumor necrosis factor alpha release from macrophages. J Pharmacol Exp Ther 2007; 324:360-7. [PMID: 17940196 DOI: 10.1124/jpet.107.130377] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Copper has an important role in cancer growth, angiogenesis, and metastasis. Previous studies have shown that cell-permeable metal ligands, including clioquinol (CQ) and pyrrolidine dithiocarbamate, inhibit cancer cell growth in cell culture and in vivo. The mechanism of action has not been fully determined but may involve metal-mediated inhibition of cancer cell proteasome activity. However, these studies do not fully account for the ability of cell-permeable metal ligands to inhibit cancer cell growth without affecting normal cells. In this study, we examined the effect of CQ on macrophage-mediated inhibition of HeLa cancer cell growth in vitro. When CQ was added to RAW 264.7 macrophage-HeLa cell cocultures, a substantial increase in HeLa cell toxicity was observed compared with CQ treatment of HeLa cells cultured alone. Transfer of conditioned medium from CQ-treated macrophages to HeLa cells also induced HeLa cell toxicity, demonstrating the role of secreted factors in the macrophage-mediated effect. Further investigation revealed that CQ induced copper-dependent activation of macrophages and release of tumor necrosis factor (TNF) alpha. In studies with recombinant TNFalpha, we showed that the level of TNFalpha released by CQ-treated macrophages was sufficient to induce HeLa cell toxicity. Moreover, the toxic effect of conditioned medium from CQ-treated macrophages could be prevented by addition of neutralizing antibodies to TNFalpha. These studies demonstrate that CQ can induce cancer cell toxicity through metal-dependent release of TNFalpha from macrophages. Our results may help to explain the targeted inhibition of tumor growth in vivo by CQ.
Collapse
Affiliation(s)
- Tai Du
- Centre for Neuroscience and Department of Pathology, University of Melbourne, Victoria, Australia 3010.
| | | | | | | | | |
Collapse
|
205
|
Stoltenberg M, Bush AI, Bach G, Smidt K, Larsen A, Rungby J, Lund S, Doering P, Danscher G. Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency. Neuroscience 2007; 150:357-69. [PMID: 17949919 DOI: 10.1016/j.neuroscience.2007.09.025] [Citation(s) in RCA: 78] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2007] [Revised: 08/20/2007] [Accepted: 09/17/2007] [Indexed: 10/22/2022]
Abstract
The ZnT3 zinc transporter is uniquely expressed in cortical glutamatergic synapses where it organizes zinc release into the synaptic cleft and mediates beta-amyloid deposition in transgenic mice. We studied the association of zinc in plaques in relation to cytoarchitectural zinc localization in the APP/PS1 transgenic mouse model of Alzheimer's disease. The effects of low dietary zinc for 3 months upon brain pathology were also studied. We determined that synaptic zinc distribution within cortical layers is paralleled by amyloid burden, which is heaviest for both in layers 2-3 and 5. ZnT3 immunoreactivity is prominent in dystrophic neurites within amyloid plaques. Low dietary zinc caused a significant 25% increase in total plaque volume in Alzheimer's mice using stereological measures. The level of oxidized proteins in brain tissue did not changed in animals on a zinc-deficient diet compared with controls. No obvious changes were observed in the autometallographic pattern of zinc-enriched terminals in the neocortex or in the expression levels of zinc transporters, zinc importers or metallothioneins. A small decrease in plasma zinc induced by the low-zinc diet was consistent with the subclinical zinc deficiency that is common in older human populations. While the mechanism remains uncertain, our findings indicate that subclinical zinc deficiency may be a risk factor for Alzheimer's pathology.
Collapse
Affiliation(s)
- M Stoltenberg
- Neurobiology, Institute of Anatomy, University of Aarhus, DK-8000 Aarhus C, Denmark.
| | | | | | | | | | | | | | | | | |
Collapse
|
206
|
Cappai R, Barnham KJ. Delineating the Mechanism of Alzheimer’s Disease Aβ Peptide Neurotoxicity. Neurochem Res 2007; 33:526-32. [PMID: 17762917 DOI: 10.1007/s11064-007-9469-8] [Citation(s) in RCA: 87] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2007] [Accepted: 07/24/2007] [Indexed: 12/21/2022]
Abstract
The Alzheimer's disease neurotoxic amyloid-beta (A beta) peptide is derived from the larger amyloid precursor protein (APP) and is the principal component of the senile plaques in Alzheimer's disease (AD) brains. This mechanism by which A beta mediates neurotoxicity or neuronal dysfunction is not fully resolved. This review will outline some of the key determinants that modulate A beta's activity and the cellular pathways and mechanisms involved.
Collapse
Affiliation(s)
- Roberto Cappai
- Department of Pathology, The University of Melbourne, Melbourne, VIC 3010, Australia.
| | | |
Collapse
|
207
|
Cauwe B, Van den Steen PE, Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 2007; 42:113-85. [PMID: 17562450 DOI: 10.1080/10409230701340019] [Citation(s) in RCA: 274] [Impact Index Per Article: 16.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Matrix metalloproteinases (MMPs) constitute a family of more than 20 endopeptidases. Identification of specific matrix and non-matrix components as MMP substrates showed that, aside from their initial role as extracellular matrix modifiers, MMPs play significant roles in highly complex processes such as the regulation of cell behavior, cell-cell communication, and tumor progression. Thanks to the comprehensive examination of the expanded MMP action radius, the initial view of proteases acting in the soluble phase has evolved into a kaleidoscope of proteolytic reactions connected to the cell surface. Important classes of cell surface molecules include adhesion molecules, mediators of apoptosis, receptors, chemokines, cytokines, growth factors, proteases, intercellular junction proteins, and structural molecules. Proteolysis of cell surface proteins by MMPs may have extremely diverse biological implications, ranging from maturation and activation, to inactivation or degradation of substrates. In this way, modification of membrane-associated proteins by MMPs is crucial for communication between cells and the extracellular milieu, and determines cell fate and the integrity of tissues. Hence, insights into the processing of cell surface proteins by MMPs and the concomitant effects on physiological processes as well as on disease onset and evolution, leads the way to innovative therapeutic approaches for cancer, as well as degenerative and inflammatory diseases.
Collapse
Affiliation(s)
- Bénédicte Cauwe
- Rega Institute for Medical Research, Laboratory of Immunobiology, University of Leuven, Leuven, Belgium
| | | | | |
Collapse
|
208
|
Dingwall C. A copper-binding site in the cytoplasmic domain of BACE1 identifies a possible link to metal homoeostasis and oxidative stress in Alzheimer's disease. Biochem Soc Trans 2007; 35:571-3. [PMID: 17511654 DOI: 10.1042/bst0350571] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The amyloidogenic processing pathway of the APP (amyloid precursor protein) generates Abeta (amyloid beta-peptide), the major constituent in Alzheimer's disease senile plaques. This processing is catalysed by two unusual membrane-localized aspartic proteinases, beta-secretase [BACE1 (beta-site APP-cleaving enzyme 1)] and the gamma-secretase complex. There is a clear link between APP processing and copper homoeostasis in the brain. APP binds copper and zinc in the extracellular domain and Abeta also binds copper, zinc and iron. We have found that a 24-residue peptide corresponding to the C-terminal domain of BACE1 binds a single copper(I) atom with high affinity through cysteine residues. We also observed that the cytoplasmic domain of BACE1 interacts with CCS, the dedicated copper chaperone for SOD1 (superoxide dismutase 1). Overproduction of BACE1 reduces SOD1 activity in cells. Consequently, SOD1 activity, cytosolic copper and ectodomain cleavage of APP are linked through BACE1.
Collapse
Affiliation(s)
- C Dingwall
- Pharmaceutical Sciences Research Division, King's College London, Franklin-Wilkins Building, Stamford Street, London SE1 9NH, UK.
| |
Collapse
|
209
|
Crouch PJ, White AR, Bush AI. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease. FEBS J 2007; 274:3775-83. [PMID: 17617225 DOI: 10.1111/j.1742-4658.2007.05918.x] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
The postmortem Alzheimer's disease brain is characterized histochemically by the presence of extracellular amyloid plaques and neurofibrillary tangles. Also consistent with the disease is evidence for chronic oxidative damage within the brain. Considerable research data indicates that these three critical aspects of Alzheimer's disease are interdependent, raising the possibility that they share some commonality with respect to the ever elusive initial factor(s) that triggers the development of Alzheimer's disease. Here, we discuss reports that show a loss of metal homeostasis is also an important event in Alzheimer's disease, and we identify how metal dyshomeostasis may contribute to development of the amyloid-beta, tau and oxidative stress biology of Alzheimer's disease. We propose that therapeutic agents designed to modulate metal bio-availability have the potential to ameliorate several of the dysfunctional events characteristic of Alzheimer's disease. Metal-based therapeutics have already provided promising results for the treatment of Alzheimer's disease, and new generations of pharmaceuticals are being developed. In this review, we focus on copper dyshomeostasis in Alzheimer's disease, but we also discuss zinc and iron.
Collapse
Affiliation(s)
- Peter J Crouch
- Department of Pathology and Centre for Neuroscience, The University of Melbourne, Australia
| | | | | |
Collapse
|
210
|
Chen WH, Wang M, Yu SS, Su L, Zhu DM, She JQ, Cao XJ, Ruan DY. Clioquinol and vitamin B12 (cobalamin) synergistically rescue the lead-induced impairments of synaptic plasticity in hippocampal dentate gyrus area of the anesthetized rats in vivo. Neuroscience 2007; 147:853-64. [PMID: 17555879 DOI: 10.1016/j.neuroscience.2007.04.042] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2007] [Revised: 04/26/2007] [Accepted: 04/27/2007] [Indexed: 11/23/2022]
Abstract
Lead (Pb(2+)) exposure in development induces impairments of synaptic plasticity in the hippocampal dentate gyrus (DG) area of the anesthetized rats in vivo. The common chelating agents have many adverse effects and are incapable of alleviating lead-induced neurotoxicity. Recently, CQ, clioquinol (5-chloro-7-iodo-8-hydroxy-quinoline), which is a transition metal ion chelator and/or ionophore with low affinity for metal ions, has yielded some promising results in animal models and clinical trials related to dysfunctions of metal ions. In addition, CQ-associated side effects are believed to be overcome with vitamin B12 (VB12) supplementation. To determine whether CQ treatment could rescue impairments of synaptic plasticity induced by chronic Pb(2+) exposure, we investigated the input/output functions (I/Os), paired-pulse reactions (PPRs) and long-term potentiation (LTP) of different treatment groups in hippocampal DG area of the anesthetized rat in vivo by recording field potentials and measured hippocampal Pb(2+) concentrations of different treatment groups by PlasmaQuad 3 inductive coupled plasma mass spectroscopy. The results show: CQ alone does not rescue the lead-induced impairments of synaptic plasticity in hippocampal DG area of the anesthetized rats in vivo; VB12 alone partly rescues the lead-induced impairments of LTP; however the co-administration of CQ and VB12 totally rescues these impairments of synaptic plasticity and moreover, the effects of CQ and VB12 co-administration are specific to the lead-exposed animals.
Collapse
Affiliation(s)
- W-H Chen
- School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, PR China.
| | | | | | | | | | | | | | | |
Collapse
|
211
|
Cappai R, Barnham KJ. Molecular determinants of Alzheimer’s disease Aβ peptide neurotoxicity. FUTURE NEUROLOGY 2007. [DOI: 10.2217/14796708.2.4.397] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
The Alzheimer’s disease amyloid precursor protein is sequentially processed to yield the neurotoxic amyloid-β (Aβ) peptide, which is the principal component of the senile plaques in Alzheimer’s disease brains. This review will outline the current thinking on how Aβ mediates neurotoxicity or neuronal dysfunction. In particular, this article will focus on the key residues that modulate Aβ’s activity and the cellular pathways and mechanisms involved. It will detail how Aβ–metal interactions are a key determinate in Alzheimer’s disease pathogenesis.
Collapse
Affiliation(s)
- Roberto Cappai
- The University of Melbourne, Department of Pathology, Bio21 Molecular Science & Biotechnology Institute, Victoria, 3010, Australia, and, The Mental Health Research Institute of Victoria, Parkville, Victoria, 3052, Australia
| | - Kevin J Barnham
- The University of Melbourne, Department of Pathology, Bio21 Molecular Science & Biotechnology Institute, Victoria, 3010, Australia, and, The Mental Health Research Institute of Victoria, Parkville, Victoria, 3052, Australia
| |
Collapse
|
212
|
Donnelly PS, Xiao Z, Wedd AG. Copper and Alzheimer's disease. Curr Opin Chem Biol 2007; 11:128-33. [PMID: 17300982 DOI: 10.1016/j.cbpa.2007.01.678] [Citation(s) in RCA: 139] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2006] [Accepted: 01/18/2007] [Indexed: 10/23/2022]
Abstract
Copper is essential for some of the enzymes that have a role in brain metabolism. Sophisticated mechanisms balance copper import and export to ensure proper nutrient levels (homeostasis) while minimizing toxic effects. Several neurodegenerative diseases including Alzheimer's disease (AD) are characterized by modified copper homeostasis. This change seems to contribute either directly or indirectly to increased oxidative stress, an important factor in neuronal toxicity. When coupled to misfolded proteins, this modified copper homeostasis appears to be an important factor in the pathological progression of AD.
Collapse
Affiliation(s)
- Paul S Donnelly
- School of Chemistry, University of Melbourne, Parkville, Victoria 3010, Australia.
| | | | | |
Collapse
|
213
|
Zatta P, Frank A. Copper deficiency and neurological disorders in man and animals. ACTA ACUST UNITED AC 2007; 54:19-33. [PMID: 17270275 DOI: 10.1016/j.brainresrev.2006.10.001] [Citation(s) in RCA: 89] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2006] [Revised: 10/16/2006] [Accepted: 10/17/2006] [Indexed: 11/29/2022]
Abstract
Copper metabolism in the brain is far from being completely understood and further studies are needed on the role of copper in the CNS, starting with careful measurements, metal and biological speciation of metabolites on the molecular level, and combining copper concentration in different brain areas with morphological as well as biochemical alteration after Cu-depletion/deficiency. So far a pathological role for copper has been clearly demonstrated in some human genetic diseases (e.g., Menkes' and Wilson's diseases), but other pathological features connected with metal depletion are under investigation in several laboratories. The metabolic interaction between copper and other metal ions in some neurological disorders is also discussed in this contribution.
Collapse
Affiliation(s)
- Paolo Zatta
- CNR-Institute for Biomedical Technologies, Department of Biology, University of Padova, 35100 Padova, Italy.
| | | |
Collapse
|
214
|
Priel T, Aricha-Tamir B, Sekler I. Clioquinol attenuates zinc-dependent beta-cell death and the onset of insulitis and hyperglycemia associated with experimental type I diabetes in mice. Eur J Pharmacol 2007; 565:232-9. [PMID: 17434477 DOI: 10.1016/j.ejphar.2007.02.064] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2006] [Revised: 02/11/2007] [Accepted: 02/13/2007] [Indexed: 11/30/2022]
Abstract
Zinc in the pancreas is co-released with insulin from beta-cells reaching concentrations similar to those found in the vicinity of glutamatergic synapses. In the brain, the role of zinc in excitotoxic brain damage is well established. In contrast, its role in islet destruction during diabetes is poorly understood. We have studied the efficacy of zinc homeostatic proteins and an intracellular zinc chelator, clioquinol, in conferring resistance against zinc toxicity in pancreatic islets. We further assessed the ability of clioquinol to protect the islets in an experimental model of type I diabetes. Our results indicate that endogenous mechanisms for lowering [Zn]i are deficient in the insulinoma cell line, MIN6, and that permeation of Zn2+ triggered cell death. Application of the low affinity, intracellular zinc chelator, clioquinol, reduced Zn2+-induced cell death by 80%. In addition, chelation of zinc ions by clioquinol in vivo prevented onset of multiple low dose streptozotocin-induced diabetes, and reduced the insulitis and hyperglycemia associated with this model. Furthermore, the glucose tolerance test (GTT) score of multiple low dose streptozotocin (MLD-STZ) mice pretreated with clioquinol was, statistically indistinguishable from that of untreated, control mice. Taken together, our results point to the potential utility of in vivo zinc chelation as a therapeutic strategy for treatment of idiopathic type I diabetes.
Collapse
Affiliation(s)
- Tsvia Priel
- Department of Physiology and Zlotowski Center for Neurosciences, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
| | | | | |
Collapse
|
215
|
Reitz C, van Rooij FJA, de Maat MPM, den Heijer T, Hofman A, Witteman JCM, Breteler MMB. Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease. The Rotterdam Study. Neurobiol Aging 2007; 29:874-81. [PMID: 17316907 DOI: 10.1016/j.neurobiolaging.2007.01.001] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2006] [Revised: 01/08/2007] [Accepted: 01/09/2007] [Indexed: 10/23/2022]
Abstract
Evidence by post-mortem and animal studies suggests that matrix metalloproteinases (MMPs) may play an important role in the pathophysiology of Alzheimer's disease (AD) through degradation of amyloid beta. We investigated in 5999 elderly whether MMP3-haplotypes are associated with cognitive performance over time, dementia and AD. We also explored the association of MMP-3 haplotypes with changes in hippocampal volume and severity of periventricular and subcortical white matter lesions (WML). There was no association between any individual polymorphism or MMP-3 haplotypes and performance in MMSE over time, dementia or AD, and there was no association between MMP-3 genotypes or haplotypes with hippocampal volume or severity of periventricular or subcortical WML. These associations did not differ between strata of APOEepsilon4 genotype. Our observations do not suggest that variation in the MMP3 gene is causally involved in dementia or AD.
Collapse
Affiliation(s)
- Christiane Reitz
- Department of Epidemiology and Biostatistics, Erasmus Medical Center, P.O. Box 1738, 3000DR Rotterdam, The Netherlands
| | | | | | | | | | | | | |
Collapse
|
216
|
Ferrada E, Arancibia V, Loeb B, Norambuena E, Olea-Azar C, Huidobro-Toro JP. Stoichiometry and conditional stability constants of Cu(II) or Zn(II) clioquinol complexes; implications for Alzheimer's and Huntington's disease therapy. Neurotoxicology 2007; 28:445-9. [PMID: 17382398 DOI: 10.1016/j.neuro.2007.02.004] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2006] [Revised: 02/04/2007] [Accepted: 02/05/2007] [Indexed: 11/21/2022]
Abstract
Successful trials with 5-chloro-7-iodo-8-hydroxyquinoline (clioquinol, CQ) for Alzheimer's disease treatment prompted renewed interest in assessing whether its therapeutic action is related to the coordination of neurotoxic trace metals, such as Cu(II) and Zn(II). We now report conditional stability constants (K(C')) for CQ Cu(II) and Zn(II) complexes measured in a biological buffer containing Ca(II) and Mg(II) ions. UV-vis spectroscopy and polarography evidenced a 1:2 stoichiometry of Cu(II) and Zn(II) CQ complexes; the K(C')s calculated were: Cu(CQ)(2) 1.2x10(10), and Zn(CQ)(2) 7.0x10(8)M(-2); the CQ affinity for Cu(II) is at least an order of magnitude higher than for Zn(II). To test the possible functional relevance of the Cu(II) CQ complexes in the brain, we bioassayed free Cu(II) concentration by the metal-induced inhibition of ATP-gated currents of the P2X(4) receptor, a predominant brain P2X receptor. CQ reduced concentration-dependently the Cu(II) inhibition of the ATP-gated currents. In view that the stability constant of CQ for Zn(II) is similar to that of Abeta-amyloid for Zn(II), and the fact that CQ may form complexes with Cu(II), even in the presence of competing ions, the present results highlight that the formation of Cu(II) CQ complexes in the brain may act by diminishing free Cu(II) concentrations modifying thereby brain excitability, or favoring the degradation of beta-amyloid plaques or huntingtin, rather than through a specific effect of CQ itself.
Collapse
Affiliation(s)
- Evandro Ferrada
- Centro de Regulación Celular y Patología, Prof. J.V. Luco e Instituto Milenio de Biología Fundamental y Aplicada, MIFAB, Departamento Fisiología, Facultad de Ciencias Biológicas y, Santiago, Chile.
| | | | | | | | | | | |
Collapse
|
217
|
Dai X, Sun Y, Jiang Z. Protective effects of vitamin E against oxidative damage induced by Abeta1-40Cu(II) complexes. Acta Biochim Biophys Sin (Shanghai) 2007; 39:123-30. [PMID: 17277887 DOI: 10.1111/j.1745-7270.2007.00261.x] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
beta-amyloid peptide (Abeta) is considered to be responsible for the formation of senile plaques, which is the hallmark of Alzheimer's disease (AD). Oxidative stress, manifested by protein oxidation and lipid peroxidation, among other alterations, is a characteristic of AD brain. A growing body of evidence has been presented in support of Abeta(1-40) forming an oligomeric complex that binds copper at a CuZn superoxide dismutase-like binding site. Abeta(1-40)Cu(II) complexes generate neurotoxic hydrogen peroxide (H(2)O(2)) from O(2) via Cu(2+) reduction, though the precise reaction mechanism is unclear. The toxicity of Abeta(1-40) or the Abeta(1-40)Cu(II) complexes to cultured primary cortical neurons was partially attenuated when (+)-alpha-tocopherol (vitamin E) as free radical antioxidant was added at a concentration of 100 mM. The data derived from lactate dehydrogenase (LDH) release and the formation of H(2)O(2) confirmed the results from the MTT assay. These findings indicate that copper binding to Abeta(1-40) can give rise to greater production of H(2)O(2), which leads to a breakdown in the integrity of the plasma membrane and subsequent neuronal death. Groups treated with vitamin E exhibited much slighter damage, suggesting that vitamin E plays a key role in protecting neuronal cells from dysfunction or death.
Collapse
Affiliation(s)
- Xueling Dai
- College of Applied Sciences and Humanities of Beijing Union University, Beijing 100083, China
| | | | | |
Collapse
|
218
|
Schäfer S, Pajonk FG, Multhaup G, Bayer TA. Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels. J Mol Med (Berl) 2007; 85:405-13. [PMID: 17211610 DOI: 10.1007/s00109-006-0140-7] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2006] [Revised: 08/25/2006] [Accepted: 11/08/2006] [Indexed: 11/29/2022]
Abstract
There is mounting evidence that the amyloid precursor protein (APP), the key protein in Alzheimer's disease (AD) is involved in the copper (Cu) homeostasis in the brain. Conflicting results about the potential use of dietary Cu and clioquinol (CQ), a known Cu chelator, have been reported using APP transgenic mice. Previously, in vitro studies have demonstrated that CQ can act as a Cu transporter. To analyze the potential function of CQ as a Cu transporter in vivo, the nutritional effect of Cu and CQ was analyzed in young APP transgenic mice and nontransgenics with food pellets containing either Cu, CQ, Cu plus CQ (Cu + CQ), or without addition of supplements (control). The offspring were fed with corresponding food pellets until the age of 14 weeks. We observed an increased lethality of APP transgenics upon CQ treatment, which could be rescued by a co-treatment with Cu. The exposure of Cu + CQ led to a modest but significant increase in cerebral Cu levels, most likely due to an enhanced transport of CQ-Cu complexes. In CQ or Cu + CQ treatment groups, the plasma levels of Cu, zinc, and iron were reduced in all animals; moreover, Cu treatment alone reduced only plasma iron levels. We conclude not only that CQ has certain toxicity but also that the chelating effect, perhaps, plays a secondary role with respect to its properties as an intracellular Cu transporter, thus, counteracting the supposed therapeutic effects of CQ as an agent for chelating therapy in AD.
Collapse
Affiliation(s)
- Stephanie Schäfer
- Department of Psychiatry, Division of Neurobiology, Saarland University, Homburg, Germany
| | | | | | | |
Collapse
|
219
|
Kim WS, Rahmanto AS, Kamili A, Rye KA, Guillemin GJ, Gelissen IC, Jessup W, Hill AF, Garner B. Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J Biol Chem 2006; 282:2851-61. [PMID: 17121837 DOI: 10.1074/jbc.m607831200] [Citation(s) in RCA: 137] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023] Open
Abstract
Maintenance of an adequate supply of cholesterol is important for neuronal function, whereas excess cholesterol promotes amyloid precursor protein (APP) cleavage generating toxic amyloid-beta (Abeta) peptides. To gain insights into the pathways that regulate neuronal cholesterol level, we investigated the potential for reconstituted apolipoprotein E (apoE) discs, resembling nascent lipoprotein complexes in the central nervous system, to stimulate neuronal [3H]cholesterol efflux. ApoE discs potently accelerated cholesterol efflux from primary human neurons and cell lines. The process was saturable (17.5 microg of apoE/ml) and was not influenced by APOE genotype. High performance liquid chromatography analysis of cholesterol and cholesterol metabolites effluxed from neurons indicated that <25% of the released cholesterol was modified to polar products (e.g. 24-hydroxycholesterol) that diffuse from neuronal membranes. Thus, most cholesterol (approximately 75%) appeared to be effluxed from neurons in a native state via a transporter pathway. ATP-binding cassette transporters ABCA1, ABCA2, and ABCG1 were detected in neurons and neuroblastoma cell lines and expression of these cDNAs revealed that ABCA1 and ABCG1 stimulated cholesterol efflux to apoE discs. In addition, ABCA1 and ABCG1 expression in Chinese hamster ovary cells that stably express human APP significantly reduced Abeta generation, whereas ABCA2 did not modulate either cholesterol efflux or Abeta generation. These data indicate that ABCA1 and ABCG1 play a significant role in the regulation of neuronal cholesterol efflux to apoE discs and in suppression of APP processing to generate Abeta peptides.
Collapse
Affiliation(s)
- Woojin Scott Kim
- Prince of Wales Medical Research Institute, Sydney, New South Wales 2031, Australia
| | | | | | | | | | | | | | | | | |
Collapse
|
220
|
Bergamini E. Autophagy: A cell repair mechanism that retards ageing and age-associated diseases and can be intensified pharmacologically. Mol Aspects Med 2006; 27:403-10. [PMID: 16973211 DOI: 10.1016/j.mam.2006.08.001] [Citation(s) in RCA: 83] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The process of ageing denotes a post-maturational deterioration of cells and organisms with the passage of time, an increased vulnerability to challenges and prevalence of age-associated diseases, and a decreased ability to survive. Causes may be found in an enhanced production of reactive oxygen species (ROS) and oxidative damage and not completed housekeeping, with an accumulation of altered ROS-hypergenerating organelles in older cells. It has been shown that autophagy is the only tier of defence against the accumulation of effete mitochondria and peroxisomes; that functioning of autophagy declines with increasing age and determinates cell and individual lifespan; that autophagy can be intensified by drugs; and that the pharmacological intensification of autophagy may be a big step towards retardation of ageing and prevention and therapy of age-associated diseases including neurodegeneration.
Collapse
Affiliation(s)
- Ettore Bergamini
- Centro di Ricerca Interdipartimentale di Biologia e Patologia dell'Invecchiamento, Via Roma 55, 56126 Pisa, Italy.
| |
Collapse
|